Developed a novel framework that enhances model selection by integrating visual inspection and scoring metrics, improving predictive model performance in clinical settings.
Background: The selection of machine learning (ML) models in the biomedical sciences often relies on global performance metrics. When these metrics are closely clustered among candidate models, identifying the most suitable model for real-world deployment becomes challenging. Methods: We developed a novel composite framework that integrates visual inspection of Model Scoring Distribution Analysis (MSDA) with a new scoring metric (MSDscore). The methodology was implemented within the Digital Phenomics platform as the MSDanalyser tool and tested by generating and evaluating 27 predictive models developed for breast, lung, and renal cancer prognosis. Results: Our approach enabled a detailed inspection of true-positive, false-positive, true-negative, and false-negative distributions across the scoring space, capturing local performance patterns overlooked by conventional metrics. In contrast with the minimal variation between models obtained by global metrics, the MSDA methodology revealed substantial differences in score region behaviour, allowing better discrimination between models. Conclusions: Integrating our composite framework alongside traditional performance metrics provides a complementary and more nuanced approach to model selection in clinical and biomedical settings.
No takes yet. Share an insight, caveat, or question.
Filho et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: